Inter Partes Review in 2026
IPR petition filings have collapsed to historic lows in 2026 — the market's rational response to Director Squires' near-zero institution rate. Continue reading this post on Patentl...
Search fresh public links, source activity, and ready-to-use post angles for Inter Partes Review.
Fresh curated links around inter partes review are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
IPR petition filings have collapsed to historic lows in 2026 — the market's rational response to Director Squires' near-zero institution rate. Continue reading this post on Patentl...
Though U.S. Patent and Trademark Office Director John Squires has drawn criticism for failing to explain his reasoning in inter partes review decisions, his recent precedential ord...
Addressing the scope of discretionary institution under the America Invents Act (AIA), the United States Patent and Trademark Office (USPTO) denied institution of inter partes revi...
In an order issued earlier this week, U.S. Patent and Trademark Office (USPTO) Director John Squires granted Director Review and partially vacated a Patent Trial and Appeal Board (...
A new inter partes review, IPR2026-00387, was filed at the Patent Trial and Appeal Board on June 5, 2026, under the caption Optiver US LLC. At this early stage, the proceeding is n...
A new inter partes review, IPR2026-00387, was filed at the Patent Trial and Appeal Board on June 5, 2026, under the caption Optiver US LLC. At this early stage, the proceeding is n...
U.S. Patent and Trademark Office Director John Squires granted three petitions for inter partes review in his newest bulk order and broke down why he previously rejected CyberSecur...
Zoom Communications, Inc. has launched a new inter partes review proceeding at the Patent Trial and Appeal Board, filing IPR2026-00411 on July 10, 2026. For patent litigators and i...
The Patent Trial and Appeal Board will no longer conduct an inter partes review into the validity of an Omni MedSci wearable device patent, now that there will be a separate post-g...
Zoom Communications, Inc. has launched a new inter partes review proceeding at the Patent Trial and Appeal Board, filing IPR2026-00411 on July 10, 2026. For patent litigators and i...
A new post-grant review at the Patent Trial and Appeal Board is worth watching for practitioners tracking early-life patent challenges and the evolving use of PTAB proceedings agai...
Another new inter partes review to watch at the Patent Trial and Appeal Board: IPR2026-00387, filed June 5, 2026, and captioned Optiver US LLC. At this early stage, the docket sign...
The U.S. Patent and Trademark Office (USPTO) today held its third PTAB Listening Session, this one focused on Patent Trial and Appeal Board (PTAB) Administration and Reform. Paneli...
A new post-grant review at the Patent Trial and Appeal Board is worth watching for practitioners tracking early-life patent challenges and the evolving use of PTAB proceedings agai...
The Patent Trial and Appeal Board’s Final Written Decision in IPR2025-00230 is a useful reminder of how decisively the Board will resolve validity disputes when the petitioner’s pr...
The Patent Trial and Appeal Board’s Final Written Decision in IPR2025-00230 is a useful reminder of how decisively the Board will resolve validity disputes when the petitioner’s pr...
Another new inter partes review to watch at the Patent Trial and Appeal Board: IPR2026-00387, filed June 5, 2026, and captioned Optiver US LLC. At this early stage, the docket sign...
Seven amici back Google's cert petition in VirtaMove, attacking the PTO's six-year 'settled expectations' bar on IPR institution and its review. Continue reading this post on Paten...
On Thursday, May 14, U.S. Patent and Trademark Office (USPTO) Director John Squires issued a Director Discretionary Decision in which he denied institution of an inter partes revie...
The U.S. Patent and Trademark Office (USPTO) on late Monday issued a notice designating as precedential a Sua Sponte Director Review Order of a Patent Trial and Appeal Board (PTAB)...
A U.S. Patent and Trademark Office decision denying a request for ex parte reexamination of a patent because it reused arguments from an inter partes review that was discretionaril...
The U.S. Patent and Trademark Office is arguing that the Federal Circuit should reject a patent challenger's appeal of Director John Squires' reversal of its successful case agains...
The Patent Trial and Appeal Board has invalidated the entirety of an Inari Medical Inc. patent covering the company's thrombectomy products, in a challenge brought by Imperative Ca...
A new inter partes review petition has been filed at the Patent Trial and Appeal Board in IPR2026-00406, a proceeding captioned Duke Manufacturing Co. and opened on July 2, 2026. F...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.